Keywords: lonza, buys, cambrex, units, million, swiss, biotechnology

Lonza buys two Cambrex units for $460 million

Article | 30 October 2006

Swiss biotechnology group Lonza has signed an agreement to purchase US drugmaker Cambrex' research bioproducts and microbial biopharmaceutical business for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lonza

Go to company listing